SOLICITATION NOTICE
Q -- Medical Services
- Notice Date
- 4/22/2004
- Notice Type
- Solicitation Notice
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive, Suite 2NE70, MSC 4811, Bethesda, MD, 20817
- ZIP Code
- 20817
- Solicitation Number
- NOI4063
- Response Due
- 5/3/2004
- Archive Date
- 5/18/2004
- Point of Contact
- William Rosa, Purchasing Agent, Phone 301-402-6655, Fax 301-480-3695, - Crystal Brown, Contracting Officer, Phone 301-402-6545, Fax 301-480-3695,
- E-Mail Address
-
wrosa@niaid.nih.gov, cbrown@niaid.nih.gov
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are not being requested and a written solicitation will not be issued. The statutory authority for this acquisition is FAR 13.501 and award is anticipated to be made under a Firm Fixed Price purchase order. The solicitation number for this acquisition is being issued as a Notice of Intent under NOI4063. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular 01-22 dated April 05, 2004. The North American Industry Classification System (NAICS) Code for this acquisition is 325413 and the small business size standard is 500. The National Institutes of Health (NIH), National Institute of Allergies and Infectious Diseases (NIAID) intends to negotiate on a sole source basis, with Invitrogen Corporation using Simplified Acquisition Procedures for a quantity of two hundred and twenty (220) 500ml. bottles and fifty (50) 1000ml. bottles of Fetal Bovine Serum (FBS)of USA origin. NIAID studies focus primarily on viruses that play an important role in disease of the respiratory and gastrointestinal tracts, the liver, and the reticuloendothelial system. Currently, NIAID employs the techniques of viral genetics and molecular biology to express protective viral antigens and attenuate viral mutants that may prove useful for prevention of disease. A number of promising live attenuated viral vaccines and virus-specific immunotherapies are under development and evaluation. NIAID conducts research directed toward defining the cause and epidemiology of medically important viral diseases and developing means for their control. LID engages in a wide range of research activities that extends from identification and antigenic characterization of viruses that cause systemic disease or acute disease of the respiratory and gastrointestinal tracts and the liver to basic molecular studies of viral structure, function, and genome organization. Scientists in the laboratory employ molecular biologic techniques to elucidate pathogenesis of disease as well as to develop purified subunit antigens and attenuated viral mutants for use in prevention of respiratory, gastrointestinal, hepatic, and systemic viral diseases. NIAID has tested and used this particular lot of FBS from Invitrogen Corporation and found it to be the only FBS that has "In Vitro Diagnostic" (IVD) documentation prior to irradiation. This documentation is necessary for future vaccine research to be conducted in the laboratory. In addition, any other sources of FBS will require extensive testing and delay experiments already in progress. The anticipated period of performance is from May 2004 though December 2004 and the place of performance is Bethesda, MD 20892. The necessary items are commercial as defined in FAR Part 2. This action is under the authority of 41 U.S.C. 253(c) (1), as set forth in FAR 6.302-1 and HHSAR 306-302-1. Only one responsible source and no other supplies or services will satisfy agency requirements. Interested parties may identify their interest and capability to respond to the requirement or submit proposals. The following FAR provisions and clauses apply to this acquisition: FAR 52.212.-1 Instructions to Offerors Commercial Items; FAR 52.212-2 Evaluation-Commercial Items; FAR 52-212-3 Offerors Representations and Certifications Commercial Items; FAR 52.212.-4 Contractor Terms and Conditions Commercial Items; FAR 52-212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders Commercial Items. A completed copy of the provisions on FAR 52.212-3 Offerors Representations and Certifications Commercial Items must be included. All offerors must be registered in the Central Contractor Registration (CCR) at http//www.ccr.gov/ to be eligible for award. This is not a request for competitive quotations. However, if any interested party believes it can perform the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other furnished information must be in writing and must contain material in sufficient detail to allow NIAID to determine if the party can perform this requirement. Capability statements must be received in the contracting office by 4:00PM EST, May 03, 3004. For delivery through the postal service the address is NIH/NIAID/AMOB, 10401 Fernwood Drive, Suite 2NE70, Room/2NE70C, MSC/4812, Bethesda, Maryland 20817-4812, Attention: William Rosa. Electronic submissions will not be accepted. Questions must be submitted in writing to William Rosa, Purchasing Agent, at wrosa@mail.nih.gov or via fax at 301-480-3695. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Solicitation number must be cited on all correspondence, NOI-4063.
- Place of Performance
- Address: National Institues of Health,, Bethesda, Maryland
- Zip Code: 20892
- Country: USA
- Zip Code: 20892
- Record
- SN00570875-W 20040424/040422211725 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |